First Tracks Biotherapeutics Inc
Status: Publicly traded
Direct answer
First Tracks Biotherapeutics Inc is publicly traded on NASDAQ under the ticker TRAX.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Can you invest in First Tracks Biotherapeutics Inc?
Yes. First Tracks Biotherapeutics Inc trades publicly on NASDAQ as TRAX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for First Tracks Biotherapeutics Inc
Detailed equity research is provided by MarketSnap.